Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Hu Wang, Zhiyuan Ma, Xiaoming Cheng, Biguang Tuo, Xuemei Liu & Taolang Li. (2020) Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer. OncoTargets and Therapy 13, pages 12427-12441.
Read now
Read now
Poupak Fallahi, Flavia Di Bari, Silvia Martina Ferrari, Roberto Spisni, Gabriele Materazzi, Paolo Miccoli, Salvatore Benvenga & Alessandro Antonelli. (2015) Selective use of vandetanib in the treatment of thyroid cancer. Drug Design, Development and Therapy 9, pages 3459-3470.
Read now
Read now
Articles from other publishers (7)
Hilal Kiziltunc Ozmen, Seda Askin, Eda Simsek, Ayse Carlioglu, Şenay Arikan & Mustafa Utlu. (2019) Mean Platelet Volume and Red Cell Distribution Width in Differentiated Thyroid Cancer Patients. Open Medicine Journal 6:1, pages 94-100.
Crossref
Crossref
Agnese Latorre, Agnese Maria Fioretti, Francesco Giotta & Vito Lorusso. (2019) Efficacy and safety of lenvatinib in an elderly patient with metastatic papillary thyroid carcinoma and cardiological comorbidity: a case report. Future Oncology 15:24s, pages 27-33.
Crossref
Crossref
Siddik Sarkar, Suraj Konar, Puvvada Naga Prasad, Shashi Rajput, B. N. Prashanth Kumar, Raj R. Rao, Amita Pathak, Paul B. Fisher & Mahitosh Mandal. (2017) Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment. Langmuir 33:31, pages 7649-7659.
Crossref
Crossref
CUN-ZHI LU, SU-SHENG CAO, WEI WANG, JUN LIU, NING FU & FENG LU. (2016) Usefulness of PET/CT in the diagnosis of recurrent or metastasized differentiated thyroid carcinoma. Oncology Letters 11:4, pages 2420-2423.
Crossref
Crossref
Xiliang Zhang, Zhonghua Wang, Lei Tian, Jiangping Xie, Guijun Zou & Futing Jiang. (2015) Increased Expression of FGF19 Contributes to Tumor Progression and Cell Motility of Human Thyroid Cancer. Otolaryngology–Head and Neck Surgery 154:1, pages 52-58.
Crossref
Crossref
Han Lin, Xian Jiang, Huaqiang Zhu, Wenjing Jiang, Xuesong Dong, Haiquan Qiao, Xueying Sun & Hongchi Jiang. (2015) 2ME2 inhibits the activated hypoxia-inducible pathways by cabozantinib and enhances its efficacy against medullary thyroid carcinoma. Tumor Biology 37:1, pages 381-391.
Crossref
Crossref
Suleyman Baldane, Suleyman H Ipekci, Mehmet Sozen & Levent Kebapcilar. (2015) Mean Platelet Volume Could be a Possible Biomarker for Papillary Thyroid Carcinomas. Asian Pacific Journal of Cancer Prevention 16:7, pages 2671-2674.
Crossref
Crossref